1-1 of 1
Hans van Tol
Close
Sort by
Journal Articles

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Brief Report
Herman Burger, Hans van Tol, Antonius W. M. Boersma, Mariël Brok, Erik A. C. Wiemer, Gerrit Stoter, Kees Nooter
Journal: Blood
Blood (2004) 104 (9): 2940–2942.
https://doi.org/10.1182/blood-2004-04-1398
Published: 2004